The Discounted Cash Flow (DCF) valuation of Guangzhou Boji Medical & Biotechnological Co Ltd (300404.SZ) is (1.58) CNY. With the latest stock price at 8.22 CNY, the upside of Guangzhou Boji Medical & Biotechnological Co Ltd based on DCF is -119.2%.
Based on the latest price of 8.22 CNY and our DCF valuation, Guangzhou Boji Medical & Biotechnological Co Ltd (300404.SZ) is a sell. selling 300404.SZ stocks now will result in a potential gain of 119.2%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 9.2% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3.87) - (1.00) | (1.58) |
| Upside | -147.1% - -112.2% | -119.2% |